Australian digital health manufacturer Atmo Biosciences has raised AUD 9.6 million and won the support of global pharmaceutical players to meet unmet clinical, consumer and medical device needs. Mr, Malcolm Hebblewhite, the CEO of Atmo Biosciences shares the goals that they are eying after achieving such astounding success.
Gut health medtech Atmo Biosciences raises $9.6m to progress ingestible capsule |Malcolm Hebblewhite
GET A FREE STOCK REPORT
Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.
Be the First to Comment